Overview  |  Endocrine Disorders  |  Infectious Diseases  |  Neuroscience  |  Cardiovascular Diseases  |  Drug Metabolism / Miscellaneous

Endocrine Disorders Superfine Humulin Suspension (SHS, a novel human insulin formulation) and insulin glargine; exhibit a longer and flatter glucodynamic profile than NPH insulin. EASD Annual Meeting, Munich Germany - 5 to 9 September 2004. The use of Basal Insulin Infusion in a Glucose Clamp alters the late Glucodynamic Profile of NPH Insulin. Annual Meeting, Munich Germany - 5 to 9 September 2004. Effect of Exenatide on digoxin pharmacokinetics. CPT Meeting, Brisbane, Australia - 1 to 6 August 2004. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord 2003 Jul;27(7):784-9 - 27 July 2003. Chronic Renal Insufficiency does not affect the Pharmacokinetics of LY333531 or that of its Active Metabolite, Compound LY338522. Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Atlanta, Georgia - 24 to 27 March 2002. Effect of Smoking on Insulin, Insulin Clearance & Time-action Profile, following Regular Insulin. 17th IDF Congress, Mexico - November 2000. Smoking Impacts Insulin Sensitivity, Insulin Clearance, and Time-action Profile following Regular Human Insulin in Chinese Men. 2nd HK Diabetes & Cardiovascular Risk Factors - East Meets West Symposium - October 2000. Pharmacodynamics and Pharmacokinetics of Subcutaneous Insulin and Insulin Lispro in 3 Ethnic Groups. 35th Annual Meeting of the EASD, Brussels - September 1999.